More Articles

Generics and biosimilars contribute to European drug savings Reports | Posted 17/10/2014

As governments around the world try to rein in healthcare expenses, generics and biosimilars can play a major role in reducing this budgetary burden [1, 2].

Mobilization of stem cells by biosimilar Nivestim and Neupogen Biosimilars/Research | Posted 17/10/2014

Comparison of biosimilar granulocyte colony-stimulating factor (G-CSF), Nivestim and originator G-CSF, Neupogen (filgrastim), showed no statistical differences when used for the mobilization of per...

Reference pricing and generics in Finland Generics/Research | Posted 17/10/2014

Reference pricing and the extension of generics substitution have produced substantial savings in antipsychotic medication costs in Finland. The daily cost of treatment with clozapine, risperidone,...

Stada in-licenses teriparatide biosimilar Biosimilars/News | Posted 17/10/2014

German generics giant Stada Arzneimittel (Stada) announced on 13 October 2014 that it had made a deal to in-licensing a teriparatide biosimilar.

French generics association promotes biosimilars Conferences | Posted 17/10/2014

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Canada bans imports from three API facilities in India Generics/General | Posted 17/10/2014

Just days after Canada’s federal department responsible for health was reported to be in talks with the US Food and Drug Administration (FDA) about Canadian generics maker Apotex, Health Canad...

Generics maker IGI Labs gains rights to AstraZeneca injectables Pharma News | Posted 17/10/2014

Speciality topical generics maker IGI Laboratories (IGI Labs) announced on 25 September 2014 that it had acquired the rights for 18 drugs from AstraZeneca.

Implications of Canadian–European Trade Agreement for generics Policies & Legislation | Posted 17/10/2014

On 26 September 2014, Canada and the European Union (EU) successfully concluded negotiations on a trade deal, which will free the movement of goods, services, investment and labour between the two...